Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit;Les traitements psychotropes prescrits dans un établissement public de santé mentale accueillant des personnes atteintes d'autisme et des polyhandicapés

Encephale

Volumn 35, Issue 4, 2009, Pages 370-376

  Armand Branger, S ^a   Poisson, N ^b   Gaudoneix Taieb M ^c   Ramos, O ^c  

^a Service Pharmacie   (France)

^b UF Évaluation Achats Médicaments ^*  (France)

^c Centre Hospitalier Paul Guiraud   (France)

Author keywords

Adult autistic; Multi handicapped patients; Polymedication; Therapeutic evaluation

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUTYROPHENONE; CYAMEMAZINE; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PHENOTHIAZINE;

ADULT; ARTICLE; AUTISM; CLINICAL EVALUATION; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISABILITY; EPILEPSY; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; PRESCRIPTION; STRUCTURED QUESTIONNAIRE; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; AUTISTIC DISORDER; COMORBIDITY; DISABILITY EVALUATION; DISABLED PERSONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; FRANCE; HOSPITALS, PUBLIC; HUMANS; HYPNOTICS AND SEDATIVES; LONG-TERM CARE; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; YOUNG ADULT;

EID: 70349119556     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2008.04.008     Document Type: Article

References (15)

1. Agence nationale pour le développement de l'évaluation médicale (ANDEM) - L'autisme, Paris, 1994, 60 pages.
2. 2C- antagonist properties of cyamemazine: signifiance for its clinical anxiolytic activity Psychopharmacology 147 2000 412 417
3. M.G. Aman, and G.M. Gharabawi Treatement of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone J Clin Psychiatry 65 9 2004 1197 1210
4. F.J. Ayd Problem with orders for medication as needed Am J Psychiatry 142 1985 939 942
5. A. Baghdadli, V. Gonnier, and F. Valancogne et al. Descriptive study of psychotropic use in the 20-35 age adults with autism in Languedoc-Roussillon Encéphale 31 3 2005 302 308
6. L. Barnard, A.H. Young, and J. Pearson et al. A systematic review of use of atypical antipsychotics in autism J Psychopharmacol 16 1 2002 93 101
7. L. Botvinik, C. Chee Ng, and I. Schweitzer Audit of antipsychoic prescribing in a private psychiatric hospital Australas Psychiatry 12 3 2004 227 233
8. H. Hida, M. Faber, and M.C. Alberto-Gondouin et al. Analyse des prescriptions de psychotropes dans un centre hospitalier psychiatrique Therapie 52 1997 573 578
9. B. Lachaux, F. Casadebaig, and A. Philippe et al. Pharmaco-epidemiology of antipsychotic prescription practices for schizophrenic patients (1995-1998 cross sectional surveys) Encéphale 30 1 2004 46 55
10. o spécial, septembre 1997
11. M.C. Mauri, F. Regispani, and S. Beraldo et al. Patterns of clinical use of antipsychotics in hospitalised psychiatric patients Prog Neuropsychopharmacol Biol Psychiatry 29 6 2005 957 963
12. P.J. Parquet, J.P. Lhuillier, and D. Malauzat La qualité de vie chez les patients psychotiques hospitalisés Synapse 105 1994 89 92
13. H. Rittmannsberger, U. Meise, and K. Schauflinger et al. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics Eur Psychiatry 14 1999 33 40
14. K. Usher, and L. Luck Psychotropic PRN : a model for best practice management of acute psychotic behavioural disturbance in inpatient psychiatric settings Int J Ment Health Nurs 13 1 2004 18 21
15. P. Voirol, P.-A. Robert, and P. Meister et al. Psychotropic drug prescription in a psychiatric University Hospital Pharmacopsychiatry 32 1999 29 37